Although significant resources are often needed to place a product on the market, regulatory activity does not stop at this point as the requirement for diligence, compliance and maintenance becomes the mainstay of a marketed product portfolio.
Addition of licences and dossiers in global markets over time inevitably leads to complexity. Although there are of course commonalities across markets and regions there are still some inherent differences, as individual Health Authorities choose to interpret regulations and guidance according to their own preferences.
Therefore it is not only selection of the right filing strategy, but also local and regional regulatory intelligence, sound scientific knowledge and a keen understanding of the clients regulatory responsibilities and commercial drivers that must be taken into account.
The importance of regulatory intelligence cannot be underestimated; it plays an integral role in defining strategy for companies in regard to compliance and maintenance of products, as well any changes to regulations impacting the global regulatory landscape.
With the regulatory landscape in constant change, it is imperative to stay current. Regulink harnesses its core team’s experience and continuous development, as well as that of our global partners to be able to support its clients in identifying and steering through optimal approval pathways.
